スペインのジェネリック医薬品の業界プロファイルでは、セクターの規模(2017〜2022 年の価値と量、および 2027 年までの予測)などの主要な定性的および定量的概要情報が提供されます。 プロファイルには、主要な財務指標やセクター内の競争圧力の分析など、主要企業の説明も含まれています。
目次
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading player?
7.3. Have there been any recent developments in the market?
8 Company Profiles
8.1. Teva Pharmaceutical Industries Limited
8.2. Viatris Inc.
8.3. Esteve Group
8.4. Novartis AG
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Spain generics market value: $ million, 2017-22
Table 2: Spain generics market volume: %, 2017-22
Table 3: Spain generics market geography segmentation: $ million, 2022
Table 4: Spain generics market value forecast: $ million, 2022-27
Table 5: Spain generics market volume forecast: %, 2022-27
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Viatris Inc.: key facts
Table 10: Viatris Inc.: Annual Financial Ratios
Table 11: Viatris Inc.: Key Employees
Table 12: Viatris Inc.: Key Employees Continued
Table 13: Esteve Group: key facts
Table 14: Esteve Group: Key Employees
Table 15: Novartis AG: key facts
Table 16: Novartis AG: Annual Financial Ratios
Table 17: Novartis AG: Key Employees
Table 18: Novartis AG: Key Employees Continued
Table 19: Spain size of population (million), 2018-22
Table 20: Spain gdp (constant 2005 prices, $ billion), 2018-22
Table 21: Spain gdp (current prices, $ billion), 2018-22
Table 22: Spain inflation, 2018-22
Table 23: Spain consumer price index (absolute), 2018-22
Table 24: Spain exchange rate, 2018-22
List of Figures
Figure 1: Spain generics market value: $ million, 2017-22
Figure 2: Spain generics market volume: %, 2017-22
Figure 3: Spain generics market geography segmentation: % share, by value, 2022
Figure 4: Spain generics market value forecast: $ million, 2022-27
Figure 5: Spain generics market volume forecast: %, 2022-27
Figure 6: Forces driving competition in the generics market in Spain, 2022
Figure 7: Drivers of buyer power in the generics market in Spain, 2022
Figure 8: Drivers of supplier power in the generics market in Spain, 2022
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Spain, 2022
Figure 10: Factors influencing the threat of substitutes in the generics market in Spain, 2022
Figure 11: Drivers of degree of rivalry in the generics market in Spain, 2022